ACOG released updated clinical guidance on vaccination for COVID-19, respiratory syncytial virus and influenza during ...

The new AAP schedule provides guidance for routine immunization against 18 diseases, including updates for RSV, influenza, and COVID-19 immunization.

A new vaccine has shown encouraging early results in patients with pancreatic and colorectal cancer, according to a clinical ...

Overall, 29% of infants born during October 2023 to March 2024 were immunized against respiratory syncytial virus (RSV) ...

RSV is the leading cause of hospitalization in US infants, and in August 2023, the CDC’s vaccine advisory group recommended ...

While most cases are mild, it can lead to bronchiolitis and pneumonia in babies and usually hundreds are hospitalised every year.

The Food and Drug Administration on Wednesday approved Arexvy, the world's first respiratory syncytial virus (RSV) vaccine — a scientific breakthrough 60 years in the making.

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is offered to prevent babies contracting the virus in the first six months of ...

GSK's RSV vaccine candidate for older adults was 82.6% effective in preventing lower respiratory tract disease defined by either two or more symptoms or and one or more signs or three or more ...

Good morning. For all our talk about potato chips in this newsletter, nobody has ever attempted to give a STAT reporter a wad ...

RSV immunisations will be available to newborns and babies aged up to six months old and the programme will run over the winter, the Minister for Health has said.